
AKUMSAkums Drugs & Pharmaceuticals Ltd.
Akums Drugs & Pharmaceuticals Q2 FY27 Results: Consolidated Net Profit ₹115 Crore on Total Income of ₹1,371 Crore
Akums Drugs & Pharmaceuticals (NSE: AKUMS) reported total income of ₹1,371.29 crore and net profit of ₹114.57 crore on a consolidated basis for the quarter ended 30 Sep 2026, and standalone total income of ₹420.84 crore and net profit of ₹32.64 crore, it said in a filing on 02 Nov 2026.
- Earnings
- pharmaceuticals